AtriCure gains amid report of Edwards Lifesciences interest

AtriCure gains amid report of Edwards Lifesciences interest
3.12BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US04963C2098
CUSIP
04963C209
Sector
Healthcare
Industry
Medical Instruments & Supplies
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
285.14
PEG Ratio
10.00
Book Value
10.15
Dividend Share
-
Dividend Yield
-
Earnings Share
0.21
Wall Street Target Price
57.56
EPS Estimate Current Year
0.28
EPS Estimate Next Year
0.43
EPS Estimate Current Quarter
0.024
EPS Estimate Next Quarter
0.0153
Most Recent Quarter
-
Revenue TTM
569,622,016
Gross Profit TTM
434,608,992
EBITDA
33,746,000
Profit Margin
1.85%
Return On Assets TTM
1.25%
Return On Equity TTM
2.15%
Revenue Per Share TTM
11.812
Qtly Revenue Growth YOY
12.80%
Diluted Eps TTM
0.21
Qtly Earnings Growth YOY
0.00%
Trailing PE
285.14
Forward PE
238
Price Sales TTM
5.3472
Price Book MRQ
6.0328
Enterprise Value Revenue
5
Enterprise Value EBITDA
78
34.45
2.28%230.00
1.57%73.44
1.37%159.30
0.00%22.78
-7.77%103.04
-1.80%196.18
-1.52%208.00
-0.86%156.25
-0.37%440.38
-0.08%